| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | General Counsel | Ordinary Shares | 174K | $3.16M | $18.19 | Mar 4, 2025 | Direct |
| NovoCure Ltd | General Counsel | Stock Options (Right to buy) | 81.5K | $1.48M | $18.19 | Mar 4, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Mar 4, 2025 | 2 | $2.48M | 4 | Mar 6, 2025 | General Counsel |
| NVCR | NovoCure Ltd | Dec 31, 2024 | 1 | $9.87K | 4 | Jan 3, 2025 | General Counsel |
| NVCR | NovoCure Ltd | Jun 28, 2024 | 1 | $11.4K | 4 | Aug 6, 2024 | General Counsel |
| NVCR | NovoCure Ltd | Feb 27, 2024 | 3 | $3.37M | 4 | Feb 29, 2024 | General Counsel |
| NVCR | NovoCure Ltd | Jun 30, 2023 | 1 | $10.2K | 4 | Jul 6, 2023 | General Counsel |
| NVCR | NovoCure Ltd | Feb 28, 2023 | 2 | $2.27M | 4 | Mar 2, 2023 | General Counsel |
| NVCR | NovoCure Ltd | Jan 6, 2023 | 1 | $9.35K | 4 | Jan 10, 2023 | General Counsel |
| NVCR | NovoCure Ltd | Jul 5, 2022 | 1 | $8.51K | 4 | Jul 7, 2022 | General Counsel |
| NVCR | NovoCure Ltd | Apr 14, 2022 | 0 | $0 | 3 | Apr 14, 2022 | General Counsel |